Where can you inject a GLP-1 pen?
Here is what each FDA label says, word for word:
| Medicine | Where to inject | Rotating |
|---|---|---|
| Ozempic | "Inject OZEMPIC subcutaneously in the abdomen, thigh, or upper arm." | "Instruct patients to use a different injection site each week when injecting in the same body region." |
| Wegovy | "Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm." | "Rotate injection sites with each dose." |
| Mounjaro | "Inject MOUNJARO subcutaneously in the abdomen, thigh, or have another person inject MOUNJARO in the back of the upper arm." | "Rotate injection sites with each dose." |
| Zepbound | "Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm." | "Rotate injection sites with each dose." |
Quoted from section 2 of each label's prescribing information on DailyMed, read November 11, 2026. Ozempic and Wegovy are trademarks of Novo Nordisk; Mounjaro and Zepbound are trademarks of Eli Lilly. FinallyMe is not affiliated with either company.
Using one of these pens? Read the details for Ozempic injection sites, Wegovy injection sites, Mounjaro injection sites, or Zepbound injection sites.
How the planner picks your next spot
The chart splits the three label areas into eight spots: the belly in four quarters around the belly button, each thigh, and the back of each upper arm. It uses the same rule as the FinallyMe app: a spot you have not used yet comes first, and after that, the spot that has rested the longest. From a fresh start that means eight different spots in eight weeks, so every spot gets about two months of rest before its turn comes back.
Switch off an area you do not use, like the arms if nobody can help you, and the planner rotates through the spots that are left.
How to rotate, step by step
- Pick your areas. Belly, thighs, and upper arms are all on the labels. For Mounjaro and Zepbound, the arm shot is one for a helper.
- Use one spot a week. Same shot day, next spot on the chart. Injection-technique guidance for insulin describes the same idea: split the belly into quarters and the thighs and arms into halves, use one part a week, and move around in the same direction (Kalra and colleagues, 2023).
- Shift a little within each spot. Keep each shot about a finger's width, 1 to 2 cm, from the last one, as the FIT Canada injection-technique recommendations suggest.
- Mind the belly button. Several official instructions, including the Wegovy pen's and the Mounjaro and Zepbound KwikPen's, say to keep belly shots at least 2 inches (5 cm) from the belly button.
- Skip any spot that is lumpy or sore, and ask your pharmacist or provider about a lump that stays.
- Write it down. Print the chart and tick each week, or let the app keep track for you.
Does the injection site change how well it works?
The Ozempic label puts it this way: "Similar exposure is achieved with subcutaneous administration of semaglutide in the abdomen, thigh, or upper arm." The Wegovy, Mounjaro, and Zepbound labels say the same about their medicines in section 12.3. See how the level builds and fades week by week with the medication level chart.
Why rotate at all?
First, because every label asks you to. Second, because of what is known from insulin: injecting the same spot again and again is linked to lipohypertrophy, a thickened, rubbery lump of fat under the skin (Gentile and colleagues, 2016), and insulin taken up from those lumps is considered slower and less predictable (Mader and colleagues, 2024).
For GLP-1 medicines the picture is calmer. The FIT Canada recommendations say current evidence indicates GLP-1 injections do not lead to lipohypertrophy, but that it is still important to rotate injection sites, and to avoid injecting into any lumpy areas. A chart makes that easy.
Questions people ask
What is the best place to inject a GLP-1?
Can I inject in the same area every week?
Can I give myself a shot in the arm?
How far from the belly button should I inject?
Can I inject in my buttocks?
Is what I tap saved anywhere?
Where the facts come from
- Ozempic (semaglutide) prescribing information, Medication Guide, and Instructions for Use. DailyMed
- Wegovy (semaglutide) prescribing information and pen Instructions for Use. DailyMed
- Mounjaro (tirzepatide) prescribing information and Instructions for Use. DailyMed
- Zepbound (tirzepatide) prescribing information and Instructions for Use. DailyMed
- Kalra S, et al. Optimising insulin injection techniques to improve diabetes outcomes. Diabetes Ther. 2023. PMC10570228
- Berard L (chair), et al. FIT Canada: Recommendations for best practice in injection technique, 3rd edition. 2017. PDF
- Gentile S, et al. Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear? Diabetes Ther. 2016. PMC5014793
- Mader JK, et al. Relationship between lipohypertrophy, glycemic control, and insulin dosing: a systematic meta-analysis. Diabetes Technol Ther. 2024. PMC11058417
More in our full list of sources and the complete GLP-1 injection guide.
